📰 Mark Leiser News
Page 2 - Mark Leiser News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Leiser. Real-time updates on events, politics, business and more.
April 22, 2023
Active surveillance by implanting physicians appeared linked to improved retrieval of inferior vena cava filters, according to results of a retrospective cohort study.Adoption of this approach significantly increased filter retrieval from 48.4% to 61.6%, results showed.
April 15, 2023
A nurse-created algorithm helped determine which patients with multiple myeloma exhibited the highest risk for pneumonia, according to study results.Cancer or its treatments can lead to low white blood cell counts.
April 5, 2023
Blogs | | Reactivation of double-stranded DNA viruses is an important cause of morbidity and mortality after hematopoietic stem cell transplantation.We highlight studies on the biology, risk factors and management of viral reactivations.
March 4, 2023
Researchers at Cleveland Clinic intend to expand their study of a novel vaccine designed to prevent triple-negative breast cancer.An ongoing phase 1A clinical trial — expected to conclude in the fourth quarter of this year — is investigating the vaccine for patients who completed treatment for early-stage, triple-negative breast cancer within the past 3 years and remain tumor free but
February 26, 2023
Adjuvant chemotherapy appeared associated with a significant survival benefit among patients with pancreatic ductal adenocarcinoma who underwent multiagent neoadjuvant chemotherapy and resection, according to study results.Investigators observed the survival benefit regardless patients lymph node status or resection margins.
February 18, 2023
SAN FRANCISCO — The newly reignited Cancer Moonshot is centered on the goal to reduce cancer deaths by 50% over the next 25 years. The oncology community must overcome several formidable challenges if that objective will be met, according to former NCI director Norman E. "Ned" Sharpless, MD.
December 30, 2022
Blogs | | Chimeric antigen receptor T-cell therapy targeting CD19 is highly effective for inducing remission among patients with relapsed or refractory B-cell acute lymphoblastic leukemia.Despite that, 50% of patients relapse after CAR-T therapy, and curative options for patients who relapse after CD19 CAR-T are limited, with no standard approach to cure.
December 28, 2022
The FDA announced several regulatory actions the past few weeks.Here is an overview of decisions that may be relevant to your practice.
November 29, 2022
The Missouri State Highway Patrol reports eight people died in traffic crashes during this year’s Thanksgiving holiday counting period.
November 29, 2022
The Missouri State Highway Patrol has issued a press release on information and statistics regarding fatalities, DWI's, and injuries across the Thanksgiving weekend. Read below to see the release. The Missouri State Highway Patrol reports eight people died in traffic crashes during this year's Thanksgiving holiday counting period--from 6 p.m. Wednesday, November 23, 2022, through 11:59 p.m. Sunday, November 27, 2022. There were no boating crashes or boating fatalities. There were two d...